Journal of Vascular Surgery
March 2012
Published as the lead article in the Journal of Vascular Surgery, Joseph V. Lombardi MD, Chief of Vascular and Endovascular Surgery, discusses the results of the STABLE trial for the minimally invasive treatment for Type B aortic dissection. “Compared to other forms of therapy for Type B aortic dissection, this approach has the lowest documented morbidity and mortality,” says Dr. Lombardi, Global principal investigator of the STABLE trial. Enrollment continues at Cooper for the STABLE trial, and is one of only 5 centers in the United States offering this groundbreaking therapy.
To read the complete article click HERE.